Health in Tech, INC Form 4 insider transactions

Timothy Hayes, a Director of Health In Tech, Inc., received 26,301 shares of common stock on October 7, 2026.

William D. Howard, a Director of Health In Tech, Inc., received 26,301 shares of common stock on October 7, 2026.

Zain Syed Hasan, Chief Growth Officer of Health In Tech, Inc., reported a transaction in 4,795 shares of common stock on September 15, 2026.

Linlin Qian, Chief Executive Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 33,725 shares of common stock on September 15, 2026.

Tim Donald Johnson, Chief Executive Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 63,339 shares of common stock on September 15, 2026.

Timothy Hayes, a Director of Health In Tech, Inc., sold 12,000 shares of common stock on September 14, 2026 for $0.89 per share.

Zain Syed Hasan, Chief Growth Officer of Health In Tech, Inc., sold 11,667 shares of common stock on September 11, 2026 for $0.92 per share.

Timothy Hayes, a Director of Health In Tech, Inc., sold 17,730 shares of common stock on September 9, 2026.

Linlin Qian, Chief Financial Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 28,183 shares of common stock on August 13, 2026.

Tim Donald Johnson, Chief Executive Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 46,327 shares of common stock on August 13, 2026.

Zain Syed Hasan, Chief Growth Officer of Health In Tech, Inc., reported a transaction in 4,007 shares of common stock on August 13, 2026.

Zain Syed Hasan, Chief Growth Officer of Health In Tech, Inc., reported a transaction in 4,084 shares of common stock on July 15, 2026.

Tim Donald Johnson, Chief Executive Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 47,217 shares of common stock on July 15, 2026.

Linlin Qian, Chief Financial Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 28,725 shares of common stock on July 15, 2026.

Health In Tech, Inc. director Sanjay K. Shrestha has executed a Power of Attorney, authorizing specific individuals to manage SEC filings related to his securities ownership and transactions.

Health In Tech, Inc. director William D. Howard has executed a Power of Attorney authorizing specific individuals to handle SEC filings related to securities ownership and transactions.

Health In Tech, Inc. director Timothy Hayes has executed a Power of Attorney, authorizing specific individuals to manage SEC filings related to his securities ownership and transactions.

Health In Tech's Chief Growth Officer, Zain Hasan, reported a transaction involving the surrender of restricted shares to cover tax obligations.

Health In Tech CEO Tim Johnson reported a transaction involving the surrender of restricted shares to cover tax obligations, impacting his direct beneficial ownership.

Health In Tech's Chief Financial Officer, LinLin Qian, has reported transactions involving Class A Common Stock, including the surrender of shares for tax withholding.

Chief Strategy Officer Jonathan Del Lockett was granted 50,000 restricted shares of Class A Common Stock tied to performance milestones.

CFO LinLin Qian surrendered 23,324 shares of Class A Common Stock to satisfy tax obligations related to restricted stock vesting.

CEO Tim Johnson surrendered 39,924 shares of Class A Common Stock to satisfy tax obligations related to restricted stock vesting.

Chief Growth Officer Zain Hasan surrendered 4,205 shares of Class A Common Stock to satisfy tax obligations related to restricted stock vesting.

CEO Tim Johnson filed an amendment to a previous Form 4 to correct a clerical error regarding his share holdings.

Chief Growth Officer Zain Hasan disposed of 3,448 shares of Class A Common Stock to satisfy tax withholding obligations.

CFO LinLin Qian disposed of 21,480 shares of Class A Common Stock to satisfy tax withholding obligations related to restricted stock vesting.

CEO Tim Johnson surrendered 35,140 shares of Class A Common Stock to satisfy tax withholding obligations following a restricted stock vest.

John McStravock, General Counsel of Health In Tech, Inc., received a grant of 5,000 restricted Class A Common Stock shares.

Sanjay K. Shrestha, a Director at Health In Tech, Inc., reported the acquisition of 13,598 Class A Common Stock shares on April 8, 2026.